Publisher
Springer Science and Business Media LLC
Reference12 articles.
1. Steiner N, Göbel G, Suchecki P, Prokop W, Neuwirt H, Gunsilius E (2017) Monoclonal gammopathy of renal significance (MGRS) increases the risk of progression to multiple myeloma: an observational study of 2935 MGUS patients. Oncotarget 9(2):2344–2356
2. Amaador K, Peeters H, Minnema MC, Nguyen TQ, Dendooven A et al (2019) Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options. Neth J Med 77:243–254
3. Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P et al (2019) The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nat Rev Nephrol 15:45–59
4. Leung N, Bridoux F, Nasr SH (2021) Monoclonal gammopathy of renal significance. N Engl J Med 384:1931–1941
5. Wiese-Hansen H, Leh F, Lodvir Hemsing A, Reikvam H (2021) Immunoglobulin-storing histiocytosis: a case based systemic review. J Clin Med 10:1834